
Michal Silverberg - Capstan Therapeutics
Nov 19, 2024 · Capstan Therapeutics is now part of AbbVie. To learn more about the announcement, click the button below. READ THE ANNOUNCEMENT
Fabio Pucci, Ph.D. - Capstan Therapeutics
Fabio is Senior Director of Venture Investments Health at Leaps. Before joining Leaps, Fabio worked at RA Capital, a biotech multistage investment fund. Before that he was a cancer …
Capstan Therapeutics Inc. (herein referred to as the “Capstan,” “we,” “us” or “our”) provides and makes available this web site located at www.capstantx.com (the “Web Site”).
IL7 increases targeted lipid nanoparticle–mediated mRNA …
Mar 21, 2024 · IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation - Capstan Therapeutics03/21/2024 Share
www.capstantx.com
www.capstantx.com
SITC 2023: IL7 increases targeted lipid nanoparticle-mediated …
Nov 4, 2023 · SITC 2023: IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell translation - Capstan Therapeutics11/04/2023 …
CAR-based therapies: opportunities for immuno-medicine beyond …
Feb 28, 2022 · CAR-based therapies: opportunities for immuno-medicine beyond cancer - Capstan Therapeutics02/28/2022 Share
Highly efficient CD4+ T cell targeting and genetic recombination …
Jun 3, 2021 · Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs - Capstan Therapeutics06/03/2021 Share